We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

134 hedge funds and large institutions have $629M invested in Arena Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $571M → $629M (+$57.6M)

9% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 47

4% less funds holding

Funds holding: 140 → 134 (-6)

21% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 28

44% less call options, than puts

Call options by funds: $34.3M | Put options by funds: $61.2M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
134
Holders Change
-6
Holders Change %
-4.29%
% of All Funds
3.89%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
43
Reduced
47
Closed
28
Calls
$34.3M
Puts
$61.2M
Net Calls
-$26.9M
Net Calls Change
-$5.34M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$13.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.3M
3
SC
Samlyn Capital
New York
+$7.25M
4
BA
BlackRock Advisors
Delaware
+$4.64M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.38M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$26.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.9M
3
Morgan Stanley
Morgan Stanley
New York
-$3.94M
4
State Street
State Street
Massachusetts
-$3.83M
5
CA
Commerzbank Aktiengesellschaft
Germany
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$3.16M -$189K -3,622 -6%
Charles Schwab
27
Charles Schwab
California
$3.13M +$58.7K +1,123 +2%
Bank of America
28
Bank of America
North Carolina
$3.1M +$1.23M +23,540 +80%
Goldman Sachs
29
Goldman Sachs
New York
$2.93M +$27.1K +518 +1%
American Century Companies
30
American Century Companies
Missouri
$2.81M -$2.72K -52 -0.1%
AllianceBernstein
31
AllianceBernstein
Tennessee
$2.42M -$253K -4,839 -10%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$2.31M +$13.1K +250 +0.6%
PAMU
33
Pictet Asset Management (UK)
United Kingdom
$2.23M +$1.99M +38,140 New
BL
34
Bolton LP
Connecticut
$2.07M +$615K +11,760 +50%
Citadel Advisors
35
Citadel Advisors
Florida
$1.82M -$338K -6,476 -17%
GH
36
GAM Holding
Switzerland
$1.59M -$10.3K -197 -0.7%
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.5M – – –
AL
38
Airain Ltd
Guernsey
$1.35M +$1.2M +23,047 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.32M -$68.6K -1,313 -6%
Nomura Holdings
40
Nomura Holdings
Japan
$1.3M -$332K -6,360 -22%
BG
41
BlackRock Group
United Kingdom
$1.28M +$383K +7,328 +50%
USAA
42
United Services Automobile Association
Texas
$1.18M +$510K +9,760 +94%
State Board of Administration of Florida Retirement System
43
State Board of Administration of Florida Retirement System
Florida
$1.16M -$185K -3,546 -15%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.1M – – –
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$1.05M – – –
CBOA
46
Commonwealth Bank of Australia
Australia
$1.04M +$310K +5,930 +50%
NFA
47
Nationwide Fund Advisors
Ohio
$986K -$24.3K -465 -3%
ARTA
48
A.R.T. Advisors
New York
$950K +$418K +7,995 +97%
PA
49
Profund Advisors
Maryland
$847K +$159K +3,048 +27%
Barclays
50
Barclays
United Kingdom
$845K +$99.4K +1,902 +13%
1
2
3 4 5

ARNA Hedge Fund Activity: Q4 2013 in Review

134 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2013, worth a combined $629M — up 10% from $571M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ARNA and 22 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 43 added.

The largest buyer was Susquehanna International Group, adding an estimated $13.4M. The largest seller was Capital World Investors, exiting entirely with an estimated $26.4M sold.

  • 134 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2013, down from 140 in Q3 2013.
  • Funds reported $629M of Arena Pharmaceuticals Inc stock for Q4 2013, up 10% quarter-over-quarter.
  • 22 funds opened new Arena Pharmaceuticals Inc positions in Q4 2013 and 28 closed out, a net change of -6 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2013 was Susquehanna International Group, an estimated $13.4M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2013 was Capital World Investors, an estimated $26.4M sold.

Based on aggregated 13F filings for Q4 2013.